ASP Isotopes Inc.ASPIEarnings & Financial Report
ASP Isotopes Inc. is a specialty materials firm focused on developing and producing high-purity custom isotopes. Its products serve key sectors including nuclear medicine, targeted cancer therapies, advanced energy, and industrial research, with customers across North America, Europe and Asia Pacific.
Revenue
$4.9M
Gross Profit
$423.2K
Operating Profit
$-15.0M
Net Profit
$-12.9M
Gross Margin
8.7%
Operating Margin
-306.1%
Net Margin
-263.7%
YoY Growth
349.5%
EPS
$-0.15
ASP Isotopes Inc. Q3 FY2025 Financial Summary
ASP Isotopes Inc. reported revenue of $4.9M (up 349.5% YoY) for Q3 FY2025, with a net profit of $-12.9M (down 75.3% YoY) (-263.7% margin). Cost of goods sold was $4.5M, operating expenses totaled $15.4M.
Key Financial Metrics
| Total Revenue | $4.9M |
|---|---|
| Net Profit | $-12.9M |
| Gross Margin | 8.7% |
| Operating Margin | -306.1% |
| Report Period | Q3 FY2025 |
Revenue Breakdown
ASP Isotopes Inc. Q3 FY2025 revenue of $4.9M breaks down across 2 segments, led by Public Civil Engineering at $3.6M (74.0% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Public Civil Engineering | $3.6M | 74.0% |
| Specialist Isotopes And Related Services | $1.3M | 26.0% |
ASP Isotopes Inc. Quarterly Revenue & Net Profit History
ASP Isotopes Inc. results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $16.7M | +1295.7% | N/A | N/A |
| Q3 FY2025 | $4.9M | +349.5% | $-12.9M | -263.7% |
Income Statement
| Q3 2025 | Q4 2025 | |
|---|---|---|
| Revenue | $4.9M | $16.7M |
| YoY Growth | 349.5% | 1295.7% |
Balance Sheet
| Q3 2025 | Q4 2025 | |
|---|---|---|
| Assets | $225.9M | $498.0M |
| Liabilities | $129.3M | $235.1M |
| Equity | $74.1M | $204.2M |
Cash Flow
| Q3 2025 | Q4 2025 | |
|---|---|---|
| Operating CF | $-8.9M | $-37.8M |